TACS-XL In Situ Apoptosis Detection Kit - DAB Summary
A complete kit for the in situ detection of DNA fragmentation.Key Benefits
• Robust method for in situ apoptosis detection
• Uses BrdU-based methods
• Precise cellular labeling
• Signal enhancing methods results in high signal-to-noise ratio
Why Use the TACS-XL In Situ Apoptosis Detection Kit - DAB?
TACS•XL DAB Kit is a complete kit for the in situ detection of DNA fragmentation. This modified TUNEL assay kit is based on the incorporation of bromodeoxyuridine (BrdU) at the 3’ OH ends of the DNA fragments that are formed during apoptosis and a specific antibody to BrdU resulting in a high signal-to-noise ratio and less sensitivity to protease-induced false positive labeling than digoxigenin or biotin-based kits.
Kit Contents
• Proteinase K
• Streptavidin-HRP
• Diaminobenzidine
• DAB Enhancer
• TACS-Nuclease
• TACS-Nuclease Buffer
• Methyl Green 1%
• TACS 2 TdT Labeling Buffer
• TACS 2 TdT Stop Buffer
• TdT Enzyme
• B-dNTP Mix
• anti-BrdU antibody
• Strep-Diluent
• Cytonin
Specifications
Limitations
For research use only. Not for diagnostic use.
Product Datasheets
Citations for TACS-XL In Situ Apoptosis Detection Kit - DAB
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
18
Citations: Showing 1 - 10
Filter your results:
Filter by:
-
ACE-2 Blockade & TMPRSS2 Inhibition Mitigate SARS-CoV-2 Severity Following Cigarette Smoke Exposure in Airway Epithelial Cells In Vitro
Authors: Hussain, SS;Libby, EF;Lever, JEP;Tipper, JL;Phillips, SE;Mazur, M;Li, Q;Campos-Gómez, J;Harrod, KS;Rowe, SM;
bioRxiv : the preprint server for biology 2024-06-24
-
Activation of sphingomyelin phosphodiesterase 3 in liver regeneration impedes the progression of colorectal cancer liver metastasis via exosome-bound intercellular transfer of ceramides
Authors: Li, Q;Li, J;Wang, K;Liao, L;Li, Y;Liang, H;Huang, C;Gan, J;Dong, X;Hu, Y;Cheng, J;Ji, H;Liu, C;Zeng, M;Yu, S;Wang, B;Qian, J;Tang, Z;Peng, Y;Tang, S;Li, M;Zhou, J;Yan, J;Li, C;
Cellular and molecular gastroenterology and hepatology 2023-05-26
-
Hypercalciuria switches Ca2+ signaling in proximal tubular cells, induces oxidative damage to promote calcium nephrolithiasis
Authors: S Shin, CL Ibeh, E Awuah Boad, BE Choi, SK Roy, BC Bandyopadh
Genes & diseases, 2021-05-15;9(2):531-548. 2021-05-15
-
Repurposing Potential of Riluzole as an ITAF Inhibitor in mTOR Therapy Resistant Glioblastoma
Authors: A Benavides-, JT Saunders, B Holmes, RN Nishimura, A Lichtenste, J Gera
Int J Mol Sci, 2020-01-05;21(1):. 2020-01-05
-
Specific blockade of Rictor-mTOR association inhibits mTORC2 activity and is cytotoxic in glioblastoma.
Authors: Benavides-Serrato A, Lee J, Holmes B, Landon K, Bashir T, Jung M, Lichtenstein A, Gera J
PLoS ONE, 2017-04-28;12(4):e0176599. 2017-04-28
-
Cellular interactions of the phosphorylated form of AKT in prostate cancer.
Authors: Hammerich K, Frolov A, Li R, Ittmann M, Ayala G
Hum Pathol, 2017-03-11;63(0):98-109. 2017-03-11
-
Chrysin induces cell apoptosis in human uveal melanoma cells via intrinsic apoptosis
Authors: C Xue, Y Chen, DN Hu, C Iacob, C Lu, Z Huang
Oncol Lett, 2016-10-13;12(6):4813-4820. 2016-10-13
-
Mechanistic Target of Rapamycin (mTOR) Inhibition Synergizes with Reduced Internal Ribosome Entry Site (IRES)-mediated Translation of Cyclin D1 and c-MYC mRNAs to Treat Glioblastoma.
Authors: Holmes B, Lee J, Landon K, Benavides-Serrato A, Bashir T, Jung M, Lichtenstein A, Gera J
J Biol Chem, 2016-05-11;291(27):14146-59. 2016-05-11
-
Persistent effect of mTOR inhibition on preneoplastic foci progression and gene expression in a rat model of hepatocellular carcinoma.
Authors: Francois-Vaughan H, Adebayo A, Brilliant K, Parry N, Gruppuso P, Sanders J
Carcinogenesis, 2016-02-10;37(4):408-419. 2016-02-10
-
Hepatic serum amyloid A1 aggravates T cell-mediated hepatitis by inducing chemokines via Toll-like receptor 2 in mice.
Authors: Ji Y, Kim H, Bae K, Lee S, Kim M, Ryoo Z
J Biol Chem, 2015-04-06;290(20):12804-11. 2015-04-06
-
Surgery combined with controlled-release doxorubicin silk films as a treatment strategy in an orthotopic neuroblastoma mouse model.
Authors: Chiu B, Coburn J, Pilichowska M, Holcroft C, Seib F, Charest A, Kaplan D
Br J Cancer, 2014-06-12;111(4):708-15. 2014-06-12
-
Anti-YKL-40 antibody and ionizing irradiation synergistically inhibit tumor vascularization and malignancy in glioblastoma.
Authors: Shao R, Francescone R, Ngernyuang N, Bentley B, Taylor S, Moral L, Yan W
Carcinogenesis, 2013-11-26;35(2):373-82. 2013-11-26
-
Chloroquine prevents progression of experimental pulmonary hypertension via inhibition of autophagy and lysosomal bone morphogenetic protein type II receptor degradation.
Authors: Long, Lu, Yang, Xudong, Southwood, Mark, Lu, Junyu, Marciniak, Stefan J, Dunmore, Benjamin, Morrell, Nicholas
Circ Res, 2013-02-27;112(8):1159-70. 2013-02-27
-
In vivo tungsten exposure alters B-cell development and increases DNA damage in murine bone marrow.
Authors: Kelly A, Lemaire M, Young Y, Eustache J, Guilbert C, Molina M, Mann K
Toxicol Sci, 2012-11-14;131(2):434-46. 2012-11-14
-
Indirubin derivative E804 inhibits angiogenesis.
BMC Cancer, 2012-05-03;12(0):164. 2012-05-03
-
Lignan transformation by gut bacteria lowers tumor burden in a gnotobiotic rat model of breast cancer.
Authors: Mabrok H, Klopfleisch R, Ghanem K, Clavel T, Blaut M, Loh G
Carcinogenesis, 2011-11-10;33(1):203-8. 2011-11-10
-
Inhibition of SAPK2/p38 enhances sensitivity to mTORC1 inhibition by blocking IRES-mediated translation initiation in glioblastoma.
Authors: Cloninger C, Bernath A, Bashir T, Holmes B, Artinian N, Ruegg T, Anderson L, Masri J, Lichtenstein A, Gera J
Mol Cancer Ther, 2011-09-12;10(12):2244-56. 2011-09-12
-
Inhibition of nuclear translocation of apoptosis-inducing factor is an essential mechanism of the neuroprotective activity of pigment epithelium-derived factor in a rat model of retinal degeneration.
Authors: Murakami Y, Ikeda Y, Yonemitsu Y, Onimaru M, Nakagawa K, Kohno R, Miyazaki M, Hisatomi T, Nakamura M, Yabe T, Hasegawa M, Ishibashi T, Sueishi K
Am. J. Pathol., 2008-10-09;173(5):1326-38. 2008-10-09
FAQs
No product specific FAQs exist for this product, however you may
View all FAQsReviews for TACS-XL In Situ Apoptosis Detection Kit - DAB
There are currently no reviews for this product. Be the first to review TACS-XL In Situ Apoptosis Detection Kit - DAB and earn rewards!
Have you used TACS-XL In Situ Apoptosis Detection Kit - DAB?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image